ISPR in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with ISPR today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Ispire Technology Inc.’s main business is supplying nicotine vaping devices, primarily under its Aspire brand. Most e-cigarette revenue comes from distributors that buy its products for resale; it also supplies devices made for other brands. Europe provides most of the company’s revenue. Sales rely heavily on Your-Buyer International Limited, which serves the United Kingdom and France, and another large distributor serving the United Kingdom.
Its smaller cannabis business designs and supplies vaping hardware to cannabis brands according to their specifications. Those customers sell the devices under their own brands, sometimes alongside the Ispire name, and supply and fill the cannabis or hemp oil themselves. Ispire sells the hardware, not the oil. It also sells nicotine pouches and assembles nicotine products in Malaysia.
Most vaping products still come from Shenzhen Yi Jia, a supplier controlled by Ispire’s CEO, Tuanfang Liu; Ispire’s Malaysian factory mainly assembles purchased components. Regulation also limits where it can sell: it is not marketing nicotine vaping products in the United States while awaiting FDA premarket approvals. For cannabis hardware, it excludes certain U.S. states and restricts sales to licensed cannabis businesses where state law requires this.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Ispire faces Smoore International, the largest legal tobacco-vapor producer by volume, while depending on Shenzhen Yi Jia for most of its vaping products.
British American Tobacco competes with Ispire for adult nicotine consumers worldwide, selling vapour and oral nicotine products through retailers while Ispire supplies vaping hardware and pouches through distributors and manufacturing arrangements. Watch BAT's vapour and oral nicotine business: its greater resources can support more aggressive pricing and promotion against Ispire.
RLX Technology's expansion outside China brings it into competition with Ispire, as both sell rechargeable and closed-system nicotine vaping products through distributors. Watch RLX's Asia-Pacific expansion and its investment in a European company, which bring it closer to Ispire's main e-cigarette markets.
Philip Morris International competes with Ispire in international nicotine markets through its VEEV e-vapor products and ZYN nicotine pouches, while Ispire supplies vaping hardware and pouches through distributors and manufacturing arrangements. Watch the reach of those products: PMI's smoke-free products were sold in 106 markets at December 31, 2025, including oral pouches in 56.
Altria's NJOY e-vapor and Helix nicotine pouch products compete with Ispire's vaping and pouch offerings, but its mainly U.S. business overlaps less with Europe-focused Ispire. Altria sells mainly to wholesalers and large retailers; its U.S. e-vapor and pouch business is the part to watch for this competition.
Philip Morris International Inc. earningsPM
Philip Morris International's report will show whether its smoke-free products are reaching more international markets, a signal of the competition Ispire faces for distributors and nicotine-product sales.
Watch the number of markets where PMI sells smoke-free products, alongside any VEEV or ZYN sales or user figures it discloses. More markets and stronger product use would mean established brands are competing for consumers and distributor access in more places, increasing pressure on Ispire's nicotine business. A pause in expansion or weaker product demand would make that competitive signal less strong, but would not show that Ispire is winning orders.
Ispire Technology Inc. earningsThis company
Ispire Technology Inc.'s report will show whether distributor orders are stabilizing and whether product sales are beginning to deliver better gross margins.
Read revenue alongside gross margin, the share of sales left after product costs. If revenue firms and gross margin improves, distributors are ordering more without the sales mix or pricing eroding the economics, and the business is repairing its profit base. If revenue firms while gross margin falls, sales are not yet translating into healthier product economics; pricing pressure, mix or inventory costs are still squeezing profit.